Aptevo Therapeutics Inc.

8-K Other events Jul 27, 2026 8-K Entered a material agreement; Regulation FD disclosure Jun 30, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure May 27, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Other events May 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Other events Mar 11, 2026 8-K Shareholder vote results Feb 19, 2026 8-K Director or officer change Feb 3, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Jan 9, 2026 8-K Amended charter or bylaws Dec 29, 2025 8-K Dec 9, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Entered a material agreement; Modified rights of security holders Oct 30, 2025 8-K Other events Sep 16, 2025 8-K Other events Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release) Aug 11, 2025 8-K Shareholder vote results Jul 24, 2025 8-K Other events Jul 1, 2025 8-K Other events Jun 30, 2025 8-K Changed accountants Jun 23, 2025 8-K Other events Jun 20, 2025 8-K Entered a material agreement; Other events Jun 20, 2025 8-K Entered a material agreement; Unregistered sale of equity Jun 17, 2025 8-K Amended charter or bylaws May 23, 2025 8-K Delisting notice or listing-rule failure; Other events May 22, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 8-K Other events Apr 29, 2025 8-K Entered a material agreement; Results of operations (earnings release); Other events Apr 28, 2025 8-K Entered a material agreement; Other events Apr 22, 2025 8-K Entered a material agreement; Other events Apr 4, 2025 8-K Regulation FD disclosure; Other events Mar 20, 2025 10-K Fiscal year ended 2024-12-31 Feb 14, 2025 8-K Results of operations (earnings release) Feb 14, 2025 8-K Regulation FD disclosure Feb 11, 2025